Breast Cancer

Breast Health

COVID-19

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecology

Imaging

Infertility

LARC

Labor and Delivery

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Procedures

Sexual Dysfunction

Sexual Health

Sexually Transmitted Diseases

Surgery

Urology

Uterine Fibroids

Vulvovaginal Candidiasis

Well Woman

About

News

Media

Podcasts

Clinical Consult

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Supplements and Featured Publications

Subscribe

Print Subscription

eNewsletter

Editorial Board

Partnerships

Poll

POLL: How do you compare with your colleagues in your comfort level for prescribing hormone replacement therapy for symptoms of menopause.

Are you comfortable prescribing HRT?

Articles

GSK plc has announced positive results for safety and tolerance of dostarlimab (Jemperli; GSK plc) in treating women with endometrial cancer.

Dostarlimab shows positive results in phase 3 trial for endometrial cancer

In a recent study, participants who had received a COVID-19 vaccine saw an average increase in menstrual cycle length of less than 1 day.

COVID-19 vaccine associated with increased menstrual cycle length

An analysis of the landmark EMPEROR-Preserved trial is providing new insights into the effects of the SGLT2 inhibitor on heart failure outcomes based on patient sex in heart failure with preserved ejection fraction (HFpEF).

In HFpEF, empagliflozin provides similar benefit for men and women

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Twitter

Facebook

YouTube

RSS Feed

Spotlight

Advances in the Management of Uterine Fibroids

CMV: In the Know

Expert Perspectives on Advances in Cervical Cancer Screening

NPWH

Supplement: Closing the Gap in Cervical Cancer Screening

Updates in the Pharmacotherapy of Endometriosis

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

View

In this educational roundtable, a multidisciplinary panel of experts explores symptoms and risk factors of CMV and highlights the unmet needs around screening and prevention.

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, share recommendations for messaging that healthcare providers should be sharing regarding CMV.

Overview and Prevalence of CMV

Signs, Symptoms, and Risk Factors for CMV

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, explore key strategies and takeaways that healthcare providers can use to discuss transmission of CMV with their patients.

CMV Transmission

Thought leaders discuss the low rates of screening for CMV and what healthcare providers can do to boost prevention efforts.

CMV Screening and Prevention

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, reveal tips regarding the most important points to emphasize when talking to patients about CMV.

The Importance of the HCP-patient CMV Conversation

Experts discuss the trajectory of CMV awareness and vaccine development efforts.

Historical Difficulty in Safely and Effectively Preventing CMV

Overview and Prevalence of CMV

EP: 1.Overview and Prevalence of CMV

EP: 2.Signs, Symptoms, and Risk Factors for CMV

EP: 3.CMV Transmission

EP: 4.CMV Screening and Prevention

EP: 5.The Importance of the HCP-patient CMV Conversation

EP: 6.Historical Difficulty in Safely and Effectively Preventing CMV